PedAM
Pediatric Disease Annotations & Medicines
| Disease | hyperparathyroidism |
| Symptom | C0022658|renal disease |
| Sentences | 14 |
| PubMedID- 20576153 | The medical management of secondary hyperparathyroidism (shpt) in patients with end-stage renal disease (esrd) involves a combination of dietary restrictions, phosphate binders, active vitamin d analogs, and calcimimetics. |
| PubMedID- 24748891 | Introduction: development of autonomous parathyroid gland function can occur in cases of long standing renal disease, leading to hyperparathyroidism and hypercalcemia. |
| PubMedID- 21955171 | Sixty-three patients including three multiple endocrine neoplasia type-1 patients had primary hyperparathyroidism, three patients with chronic renal disease (crd) had tertiary hyperparathyroidism, three patients with crd and two renal transplanted patients had persistent secondary hyperparathyroidism. |
| PubMedID- 26224587 | Cinacalcet is a calcimimetic agent licensed for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease, and for the reduction of marked hypercalcemia in patients with parathyroid carcinoma and sporadic hyperparathyroidism requiring surgery but for whom parathyroidectomy is contraindicated. |
| PubMedID- 22868729 | Purpose: to evaluate the means for diagnosis and treatment of secondary hyperparathyroidism in patients with end-stage renal disease undergoing regular hemodialysis. |
| PubMedID- 23026501 | The recently described sagliker syndrome (ss) might be an exaggerated version of rod and is a very striking and prominent feature of secondary hyperparathyroidism in patients with end-stage renal disease (esrd). |
| PubMedID- 24554674 | Chronic renal disease is often associated with secondary hyperparathyroidism (hpp) and rarely with tertiary hpp. |
| PubMedID- 26268579 | Background: observational data suggest that serum magnesium (mg) concentration is inversely related to vascular calcification and hyperparathyroidism among patients with end-stage renal disease (esrd). |
| PubMedID- 25111639 | Objective: the goal of this study is to compare patient-reported quality of life (prqol) evolution between two groups of end-stage renal disease patients with secondary hyperparathyroidism (shpt). |
| PubMedID- 25434503 | Young age, male sex, and end-stage renal disease with secondary hyperparathyroidism as risk factors for intraoperative hyperkalemia during parathyroidectomy. |
| PubMedID- 21534240 | Smoking and hyperparathyroidism in patients with end-stage renal disease (esrd). |
| PubMedID- 26531277 | Objective: we wished to explore short-term efficacy of surgical treatment of secondary hyperparathyroidism in patients with the end-stage renal disease. |
| PubMedID- 21716690 | Medical treatment is the main strategy to control secondary hyperparathyroidism in patients with end-stage renal disease (esrd). |
| PubMedID- 24440084 | Objectives: we conducted a retrospective cohort study to investigate the risk of cancer in end stage renal disease (esrd) patients with secondary hyperparathyroidism (hpt). |
Page: 1